{"id":"W4200101750","doi":"10.1182/bloodadvances.2021005240","title":"Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Oncology; Risk analysis (engineering); Risk assessment; Myelodysplastic syndromes; Internal medicine; Intensive care medicine; Computer science; Cancer; Computer security; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000393211,0.0002392444,0.0006034285,0.0003405359,0.0000831936,0.00004135297,0.0001621696,0.0001386273,0.0002971388],"category_scores_gemma":[0.0009978905,0.0002048043,0.00005899384,0.001338875,0.0001043744,0.0003997987,0.000106951,0.0006378967,0.0001333449],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002976927,"about_ca_system_score_gemma":0.0007664477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002653745,"about_ca_topic_score_gemma":0.001652868,"domain_scores_codex":[0.9975888,0.0001461201,0.0005511263,0.0005773591,0.0005141499,0.000622497],"domain_scores_gemma":[0.9987497,0.0004211172,0.0001495272,0.0003536155,0.0001652303,0.0001608311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004920709,0.006671849,0.8145897,0.00243523,0.0003403852,0.04281812,0.001079677,0.001573498,0.04812396,0.00142807,0.0002820171,0.07573679],"study_design_scores_gemma":[0.03423721,0.002198597,0.8354131,0.001974333,0.0002494911,0.003829114,0.001490082,0.006209093,0.109427,0.00200086,0.002164288,0.0008068673],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946753,0.001976667,0.00005924475,0.0008477909,0.0001029757,0.0006906065,0.00004627973,0.00006847775,0.00153261],"genre_scores_gemma":[0.9902943,0.001962308,0.003873522,0.0001166547,0.00003749377,0.0001867043,0.00009661955,0.00003972325,0.003392718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07492992,"threshold_uncertainty_score":0.8351679,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01540673069825848,"score_gpt":0.2841526436120235,"score_spread":0.268745912913765,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}